4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-049550
Director acquired 31,892 shares (option exercise)
- Director gave up 9,649 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
HOLLER FRANK A · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-09-12 | Exercise or conversion : show line 1 in the form | +3,086 | $3.70 | $11,418 | 122,041 | D |
| 2019-09-12 | Shares withheld for taxes : show line 2 in the form | −934 | $9.38 | $8,761 | 121,107 | D |
| 2019-09-12 | Exercise or conversion : show line 3 in the form | +3,086 | $3.07 | $9,474 | 124,193 | D |
| 2019-09-12 | Shares withheld for taxes : show line 4 in the form | −934 | $9.38 | $8,761 | 123,259 | D |
| 2019-09-12 | Exercise or conversion : show line 5 in the form | +25,720 | $3.00 | $77,160 | 148,979 | D |
| 2019-09-12 | Shares withheld for taxes : show line 6 in the form | −7,781 | $9.38 | $72,986 | 141,198 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-09-12 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −3,086 | 0 | D |
| 2019-09-12 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −3,086 | 0 | D |
| 2019-09-12 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −25,720 | 0 | D |
Loading xslF345X03/doc4.xml…